TTKHLTCARE

TTK Healthcare .’s fall to its 52-week low on 15 Dec 2025 reflects a combination of subdued sales growth, declining core profitability, and limited institutional interest. The stock’s technical indicators remain weak, trading below all major moving averages, while its valuation metrics suggest a premium relative to peers despite recent price declines. The company’s financial profile, including a low debt load and moderate ROE, provides some stability, yet the overall market response indicates ongoing challenges in delivering sustained shareholder value.